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INTRODUCTION 
The term ‘apical periodontitis’ is generally used to describe and 
group together, the various periapical conditions that originate from 
necrosed or diseased pulp. Any break in the integrity of the external 
tooth surface by dental caries, chemical erosion, or cracks etc. may 
result in irritation of the pulp.
39
 In these situations the bacterial elements 
may reach the pulp and cause a tissue response. Without proper 
treatment, the pulp’s inflammatory processes may spread and eventually 
pulp necrosis will occur. In conjunction with this spread of 
inflammation through the apical foramina, apical periodontitis may be 
induced. 
 According to Fabricius et al, the infected and necrotic root canal 
system offers a selective environment for causative organisms, which 
grow mostly in sessile biofilms and also as aggregates, co-aggregates 
and planktonic cells suspended in the fluid phase of the canal. 
Collectively this polymicrobial community residing in the root canal 
system has several biologic and pathogenic properties, such as 
antigenicity, chemotaxis and activation of host cells (Nair et al). 
 The microbial invaders in the root canal can advance or their by-
products can infiltrate the periapex. In response the host mounts a 
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dynamic defensive system consisting of several classes of cells, 
intercellular messengers, antibodies and effector molecules. The clash of 
the microbial and host defense forces destroys much of the periapical 
tissues. As a consequence of the microbial infection of the root canal 
system and the inability of the host defense responses to eliminate the 
antigens, periapical lesions such as apical abscesses, granulomas and 
cysts may be formed with the aim of restricting microbes.
23 
 Due to the encasement of the root in bone and the relatively 
greater resistance of the root to resorption, the production of an 
inflammatory infiltrate usually occurs at the expense of the surrounding 
bone. The changes in mineralization and structure of the bone adjacent 
to the site of inflammation form the basis of radiographic diagnostic 
procedures for the detection and monitoring of apical periodontitis.
14 
 Although the defensive reaction minimizes the spread of the 
infection, it cannot eliminate microbes that are well entrenched in the 
sanctuary of the root canal system as protected biofilms. Therefore 
apical periodontitis is not self healing. Resolution requires surgical or 
non surgical endodontic therapy. 
 The universal goal of the root canal treatment is to prevent or 
cure apical periodontitis, caused by the infection of the root canal 
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system. When the treatment is done properly, healing of the periapical 
lesion usually occurs with hard tissue regeneration, that is characterized 
by reduction of the radiolucency on follow-up radiographs. 
 Periradicular surgery, when indicated, should be considered as an 
extension of nonsurgical treatment, because the underlying etiology of 
the disease process and the objectives of treatment are the same: 
prevention and elimination of apical periodontitis.
40
 Even when surgical 
treatment is the likely definitive approach, nonsurgical therapy before 
the procedure may be recommended to help reduce the number of 
microorganism in the root canal system and ensure a more favorable 
long term prognosis.
40 
 Periapical radiolucencies persist when treatment procedures have 
not reached a satisfactory standard for the control and elimination of the 
infection. Problems that lead to persistent apical periodontitis include: 
inadequate aseptic control, poor access cavity design, missed canals, 
inadequate instrumentation, debridement and leaking temporary or 
permanent restorations. Even when the most stringent procedures are 
followed, apical periodontitis may still persist as asymptomatic 
radiolucencies, because of the complexity of the root canal system 
formed by the main and accessory canals, their ramifications and 
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anastomoses where residual infection can persist.
22
 In addition, there are 
factors located beyond the root canal system within the inflamed 
periapical tissue, that can interfere with the post-treatment healing of the 
lesion [Nair & Schroeder 1984]. 
 Due to the persistent microbial infection and the increased 
inflammatory response, periapical lesions tend to grow within the jaw 
bone. It is understandable that intense bone resorption produced by 
activated osteoclasts may favor the intraosseous expansion of the 
lesion.
26  
Very little is currently known about the precise mechanisms of 
the growth of apical periodontitis lesions. 
 Oncostatin M(OSM)  is a pleiotropic cytokine that is produced by 
activated T cells and macrophages at the time of inflammation.
16
The 
glycoprotein is structurally and functionally related to IL-6, leukemia 
inhibitory factor (LIF), and IL-11, proteins that also influence immune 
and inflammatory function. OSM regulates cell growth and 
differentiation in a wide variety of biological systems, including 
hematopoiesis, neurogenesis and osteogenesis.
6 
Numerous activities 
have been ascribed to OSM expression in vitro, including the 
differentiation of megakaryocytes, inhibition of tumor cell growth, 
induction of neurotrophic peptides, regulation of cholesterol 
Introduction 
 
 
5 
 
metabolism, and effects on bone-derived cells.
37
There is a strong 
evidence implicating that OSM can participate in bone remodeling. 
Moonga et al studied the effects of OSM in isolated rat osteoclasts.
20 
Richards et al (2000) have demonstrated the role of OSM in the 
induction of osteoclast differentiation and resorptive activity in the 
mouse. OSM is regarded as the proinflammatory cytokine that may be 
responsible for the bone resorption associated with apical periodontitis.  
 The aim of the present study was to investigate the expression of 
OSM in persistent apical periodontitis lesions by immunohistochemical 
analysis.  
The objective of the present study was: 
1. To investigate the expression of OSM in persistent apical 
periodontitis lesions  
2. To compare the OSM expression in apical periodontitis 
lesions of size greater than 5 mm and size less than 5 mm. 
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REVIEW OF LITERATURE 
Kakaheshi et al (1965)
15
 reviewed the influence of viable micro-
organisms on the fate of a surgically exposed dental pulp. The study was 
undertaken using germ free animals. He showed that the integrity of an 
unexposed dental pulp can be maintained after severe injury only in the 
absence of a bacterial infection. He concluded that the presence or 
absence of microbial flora is the major determinant in the healing of 
exposed rodent pulps. 
 Mikkonen M et al (1983) investigated healing after periapical 
surgery by studying clinical and radiolographic features in 108 patients 
in whom apicoectomy was performed. Histologic diagnosis was used to 
determine healing results. He found that teeth with periapical granuloma 
tend to heal less successfully than teeth showing inflammation or cysts. 
Postoperative treatment played an important role in the healing process. 
He explained age of the patient also has some influence on healing. 
 Lustmann et al (1991) studied the relation of pre-operative and 
intraoperative factors to prognosis of posterior apical surgery. The 
relation of preoperative and intraoperative factors to the prognosis of 
apical surgery was studied in 136 premolar and molar roots. The 
evaluated factors were: clinical signs and symptoms, size of the 
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periapical lesion, root canal obturation, tooth restoration, apical 
retrofilling, and the operating surgeon. He found a significantly higher 
success rate in roots obturated 2 mm or shorter of the apex, in roots 
without post restoration, and after retrofilling of roots with apparently 
well-condensed obturation. 
 Bellido et al (1995)
2
 reviewed the functional receptor complexes 
assembled in response to interleukin-6 and -11 (IL-6 and IL-11), 
leukemia inhibitory factor (LIF), oncostatin M (OSM), and ciliary 
neurotrophic factor (CNTF). IL-6 and IL-11 induce homodimerization 
of gp130, while the rest heterodimerize gp130 with other gp130-related 
beta subunits. Some of these cytokines (IL-6, IL-11, and CNTF) also 
require a specificity-determining alpha subunit not directly involved in 
signaling. He concluded that stromal/osteoblastic cells are targets for the 
actions of all the members of the cytokine subfamily that shares the 
gp130 signal transducer and suggested that different receptor repertoires 
may be expressed at different stages of differentiation of this lineage. 
 Bruce et al (1996)
6
 reviewed Oncostatin M (OSM) cytokine 
whose structural and functional features are similar to other members of 
the interleukin (IL)-6 family of cytokines, many of which utilize gp130 
as a common receptor subunit. A biologically active OSM receptor has 
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been previously described that consists of a heterodimer of leukemia 
inhibitory factor receptor (LIFR) and gp130. This LIFR gp130 complex 
is also a functional receptor for LIF. He cloned and characterized an 
alternative subunit (OSMRb) for an OSM receptor complex (a 
heterodimer of gp130 and OSMRb) that is activated by OSM but not by 
LIF. He demonstrated that both LIF and OSM cause tyrosine 
phosphorylation and activation of the gp130 LIFR combination, but the 
gp130-OSMRb complex is activated by OSM only. He concluded that 
OSM-induced cellular responses, initiated through low affinity binding 
to gp130, are mediated by two heterodimeric receptor complexes that 
utilize alternative signal transducing subunits that confer different 
cytokine specificities to the receptor complex. 
 Danin J et al (1996) compared the outcome of retreatment and 
surgical intervention in root canal treated teeth with nonhealing perira- 
dicular pathosis. He found that the success rate for surgery was higher 
than for conventional retreatment, but the difference was not statistically 
significant. He concluded that for management of nonhealing 
periradicular pathosis associated with root canal treated teeth, surgical 
intervention should be considered as an alternative to retreatment. 
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 Wang hui et al (1997)
12
 measured OSM in synovial fluid found 
in patients with rheumatoid arthritis and osteo-arthritis. He found that 
OSM was detected in 18 or 20 samples of synovial fluid from 
rheumatoid arthritis patients. There was no detectable OSM in synovial 
fluid from osteo-arthritis patients. He concluded that OSM may 
contribute to joint inflammation in rheumatoid arthritis.  
 Bohic et al (1998)
3
 reviewed the effects of LIF and OSM on the 
physicochemical characteristics of mineral phase formed in a rat bone-
marrow stromal cell culture model. He analysed the  physicochemical 
characteristics of the mineralization nodules formed were analyzed by 
energy dispersive X ray microanalysis (EDX) and Fourier transform 
infrared (FT-IR) and FT-Raman spectroscopy. EDX and FT-IR 
spectroscopy revealed the influence of LIF and OSM on the 
physicochemical characteristics of mineral phases. FT-Raman 
spectroscopy showed modifications of the main vibrational modes of the 
organic matrix. He concluded that these alterations induced by growth 
factors could help define new strategies for the prevention and treatment 
of skeletal disorders. 
 Alan grenier et al (1999)
9
 investigated the potential production 
and regulation of OSM by human polymorphonuclear neutrophils. He 
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found that OSM secretion occurs through a two step mechanism in 
PMN, consisting of early release of a preformed stock, followed by 
denovo protein synthesis. This would allow rapid and sustained OSM 
release to occur at an inflammatory site and may contribute to the 
modulation of local inflammation. 
 Gomez et al (1999)
7
 reviewed the action of oncostatin over wide 
variety of cells and its diversified biological responses in vivo and in 
vitro. He suggested the potential role of oncostatin in the regulation of 
complex cellular processes such as gene activation, cell survival, 
proliferation and differentiation. OSM is a multifunctional cytokine that 
is structurally and functionally related to the sub family of cytokines IL-
6. OSM shares properties with all members of this family but is most 
closely related to LIF. He concluded that OSM and LIF can bind to the 
same functional receptor complex and thus mediate overlapping spectra 
of biological activities.  
 Lisignoli et al (1999)
18
 demonstrated both in vitro and ex vivo 
the role of mature osteoblasts (OB) and bone marrow stromal cells 
(BMSC) in Rheumatoid arthritis(RA) and Osteo-arthritis(OA)  by 
analysing the expression of the following IL-6-type cytokines: IL-11, 
leukaemia inhibitory factor (LIF), oncostatin M (OSM) and IL-6.The 
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evolution of OA and RA is characterized by processes of bone 
remodelling: in OA, subchondral bone stiffness increases, while 
erosions and osteonecrosis are typical features of RA bone. OB and 
BMSC were isolated from femora of RA, OA and post-traumatic (PT) 
patients, cultured in vitro in the presence or absence of IL-1b and tumor 
necrosis factor-alpha (TNF-a), and assessed for the production and 
mRNA expression of IL-6-type cytokines. He demonstrated that IL-6-
type cytokines are constitutively expressed in the bone compartment in 
RA, OA and PT patients and can be secreted by bone cells at different 
stages of differentiation (BMSC and OB). This suggests that these 
cytokines may be involved in the mechanisms of bone remodeling in 
OA and RA. 
 Marc vase et al (1999)
35
 analyzed the effect of oncostatin M 
(OSM) on angiogenesis, as it could be involved in the development of 
atherosclerosis. The effect of OSM was compared with those of 
leukemia inhibitory factor (LIF) and interleukin-6(IL-6). On human 
dermal microvasculature endothelial cells (HMEC-1s), OSM (22.5 to 
112.5 pmol/L) induced a dose-dependent increase in cell proliferation 
greater than that induced by the classic angiogenic factors vascular 
endothelial growth factor and basic fibroblast growth factor (Bfgf), LIF  
induced only a 30% increase in cell proliferation, and IL-6 had no effect. 
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He concluded that OSM induces an angiogenic effect on capillary 
endothelial cells, which could be, at least in part, implicated in 
pathological processes such as atherosclerosis or tumor growth. 
 Samuel Varghese et al (1999)
34
 reviewed the effects of 
Leukemia inhibitory factor (LIF) and oncostatin M (OSM) on skeletal 
remodeling. He tested whether LIF and OSM regulate the expression of 
matrix metalloproteinases (MMPs) and tissue inhibitors of 
metalloproteinases (TIMPs) in osteoblasts enriched cells isolated from 
fetal rat calvariae. He concluded that LIF and OSM stimulate 
collagenase-3 and TIMP-1 expression in osteoblasts and these effects 
may be involved in bone remodeling actions of these cytokines. 
 Wallace et al (1999)
37
 reviewed OSM, which is a pleiotropic 
cytokine produced late in the activation cycle of T lymphocytes and 
macrophages. He showed that administration of OSM inhibited bacterial 
LPS-induced production of TNF and lethality in a dose dependent 
manner. Consistent with these findings, OSM potently suppressed 
inflammation and tissue destruction in murine models of rheumatoid 
arthritis and multiple sclerosis. He concluded that the activities of this 
cytokine in vivo are anti-inflammatory without concordant 
immunosuppression. 
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 Bruce et al (2000)
6
 reviewed OSM which is a pleiotropic 
cytokine regulating cell growth and differentiation in a wide variety of 
biological systems, including hematopoiesis, neurogenesis and 
osteogenesis. The elaboration of the biological activities of OSM has 
been confounded by the presence of different OSM receptor signaling 
systems in humans. He concluded that OSM signals threw two different 
receptor complexes-the LIF/OSM shared receptor, which shares high 
affinity binding with LIF, a protein with structural similarity to OSM 
and the OSM specific receptor which binds OSM uniquely 
 Carrie Langdon et al (2000)
16
 reviewed OSM that can regulate 
a number of connective-tissue cell types in vitro including cartilage and 
synovial tissue-derived fibroblasts, however its role in joint 
inflammation in vivo is not clear. He analyzed murine OSM (mu OSM) 
activity in vitro and in vivo in mouse joint tissue, to determine the 
potential role of this cytokine in local joint inflammation and pathology. 
He concluded that OSM regulates synovial fibroblast function 
differently than other IL-6-type cytokines, and can induce a proliferative 
invasive phenotype of synovium in vivo in mice on overexpression. He 
suggested that OSM may contribute to pathology in arthritis. 
Review of literature 
 
 
14 
 
. Heymann et al (2000)
11
 reviewed the role of gp130 cytokine 
family in bones cell differentiation or activation and in osteo-articular 
pathologies. This family included IL-6, IL-11, OSM, LIF, cilliary 
neurotropic factors and cardiotropin. He reported the role of IL-6 in 
bone destruction in malignant hypercalcemia. IL-11 may induce the 
formation of osteolytic bone metastasis. LIF and OSM promoted 
cartilage degradation in rheumatoid arthritis patients. He concluded that 
detection of gp130 family cytokines in osteo-articular pathologies is a 
definitive indication of the importance in these disease processes. 
 Richards et al (2000)
25
 demonstrated the role of OSM in the 
induction of osteoclast differentiation and resorptive activity in the 
mouse. He examined the ability of recombinant OSM to stimulate 
osteoclast formation and compared the responses to other members of 
the IL-6 family of cytokines including mouse leukemia inhibitory factor, 
cardiotropin-1 and IL-6. He concluded that mouse OSM, cardiotropin-1 
and leukemia inhibitory factor induce osteoclast differentiation and 
activation. 
 Wahl et al (2001)
36
 suggested that OSM is anabolic, anti 
inflammatory, and promotes wound healing. In models of inflammation 
OSM is produced late in the cytokine response promoting the re-
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establishment of homeostasis by co-operating with pro inflammatory 
cytokines and acute phase molecules to alter and attenuate the 
inflammatory response. In animal models of chronic inflammatory 
disease OSM potently suppressed inflammation and tissue destruction. T 
cell function and antibody production were not impaired by OSM 
treatment. He indicated that activities of this cytokine in vivo or anti-
inflammatory without concordant immunosuppression. 
 Moonga et al (2002)
20
 compared the effects of IL-6, OSM, 
leukemia inhibitory factor on bone resorption and cytosolic calcium 
signaling. He concluded that IL-6R activation by IL-6 stimulates 
osteoclastic bone resorption either by reversing the inhibitory effect of 
high extracellular calcium in stromal containing systems or itself 
stimulating bone resorption along with calcium ions by micro-isolated 
osteoclasts 
 Palmqvist et al (2002)
24
 studied the bone resorptive effects of 
IL-6, OSM and leukemia inhibitory factor and their regulation of 
receptor activator of NF-Kb  ligand(RANKL),RANK, osteoprotegrin 
(OPG) in neonatal mouse calvaria .He demonstrated stimulation of 
calvarial bone resorption and regulation of mRNA and protein 
expression of RANKL & OPG by IL-6 family cytokines. 
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 Sisko Huumonen et al (2002)
14
 reviewed the advantages and 
limitations of the radiological examination in periapical diagnosis. He 
suggested that diagnosis and management of periapical pathosis requires 
a thorough clinical and radiographic examination. Along with normal 
radiographic techniques other imaging techniques like tomography, 
computed tomography, Magnetic resonance imaging, Ultrasound and 
nuclear techniques have been reviewed. He concluded that radiographic 
diagnosis of chronic apical periodontitis is a complex task, which is 
confounded by several anatomical and biological variables. Between the 
extremes of well-defined, normal periapical structures and 
pathognomonic radiolucencies, detection and grading of radiographic 
signs of chronic apical periodontitis may be difficult. Systems for 
training and calibration of observers may be used to improve diagnostic 
performance, and digital manipulations have great potential for the 
detection of subtle changes indicating disease. 
 Spence et al (2002)
29
 revealed OSM – mediated expression of m-
RNA’s encoding tissue type plasminogen activator (tPA) and 
plasminogen activator inhibitor 1 (PAI-1). Northern blot analysis 
showed that the level of tPA – mRNA expression is nearly undetectable 
in calu-1 cells. Exposure of these cells to OSM for 20 hours increased 
tPA – mRNA expression by twenty fold and PAI-1 mRNA expression 
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by five fold. He showed that plasminogen activating system has shown 
to participate in degradation of bone like matrix and implicated OSM 
has a mediator of bone destruction.   
 Takafumi et al (2002)
30
 measured the protein levels of OSM in 
the supernatants of dendritic cells cultures by ELISA and examined the 
expression of OSM mRNA by RT-PCR after stimulation with 
lipopolysaccharide (LPS) or fixed Staphylococcus aureus. He concluded 
that human monocyte-derived DCs can synthesize and secrete large 
amounts of OSM in response to bacterial products, suggesting that OSM 
produced by DCs at infectious sites may play a role in modulating 
inflammatory responses. 
 Tsai et al (2002)
32
 reviewed the role of COX 2 which is a key 
enzyme in prostaglandin synthesis, in the pathogenesis of pulpal or 
periapical lesions. He investigated the in situ localization of COX 2 in 
radicular cysts using immunohistochemistry. A peroxidase-labelled 
strepdavidin-biotin technique was used for the identification of COX 2. 
He concluded that the COX 2 expression is significantly higher in 
radicular cysts and COX 2 played an important role in the pathogensis 
of radicular cysts. 
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 Nair et al (2004)
23
 reviewed the pathogenesis of apical 
periodontitis and the causes of endodontic failures. He viewed apical 
periodontitis as a dynamic encounter between microbial factors and host 
defenses at the interface between the infected radicular pulp and 
periodontal ligament that results in local inflammation, resorption of 
hard tissues and eventual formation of various histopathologic 
categories of apical periodontitis, commonly referred to as periapical 
lesions. He concluded that even when the highest standards and most 
careful procedures are followed, failures still occur. He explained that 
this is because there are root canal regions that are inaccessible by the 
current equipments and that is the reason for persistent infection. 
 Shih – junglin et al (2004)17 investigated the presence of OSM 
and IL-6 in gingival crevicular fluid. He showed that both OSM and IL-
6 were detected in most gingival crevicular fluid samples. The total 
amounts of IL-6 & OSM were significantly positive correlated with 
severity of diseased sites. He concluded that both OSM & IL-6 may play 
a role in modulating the inflammatory cascade of chronic periodontitis. 
 Wang hui et al (2004)
13
 demonstrated that Oncostatin M is a 
pro-inflammatory cytokine previously shown to promote marked 
cartilage destruction both in vitro and in vivo when in combination with 
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IL-1 or tumor necrosis factor alpha. He reviewed the in vivo effects of 
these potent cytokine combinations on bone catabolism are unknown. 
Using adenoviral gene transfer, he over expressed oncostatin M in 
combination with either IL-1 or tumor necrosis factor alpha intra-
articularly in the knees of C57BL/6 mice. Both of these combinations 
induced marked bone damage and markedly increased tartrate-resistant 
acid phosphatase-positive multinucleate cell staining in the synovium 
and at the front of bone erosions. Furthermore, there was increased 
expression of RANK and its ligand RANKL in the inflammatory cells, 
in inflamed synovium and in articular cartilage of knee joints. He 
concluded that this model of inflammatory arthritis demonstrates that, in 
vivo, oncostatin M in combination with either IL-1 or tumor necrosis 
factor alpha represents cytokine combinations that promote bone 
destruction.  
 Goren et el (2006)
8
 investigated the role of the cytokine 
oncostatin M (OSM) for wound biology. OSM and its specific OSM 
receptor subunit β (OSMRβ) were induced upon injury. OSM induction 
paralleled the early influx of polymorphonuclear neutrophils (PMN) into 
the wound. OSM protein was localized in PMN in very early wounds, 
whereas OSMRβ could be detected on macrophages, keratinocytes, and 
fibroblasts later in repair. To establish a functional connection between 
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PMN and OSM expression in wounds, we depleted mice from 
circulating PMN by injecting an anti-PMN monoclonal antibody               
(Ly-6G). PMN-depleted wounds were characterized by a nearly 
complete loss of OSM but not OSMRβ mRNA and protein expression 
within the initial 16–24 hours after injury. He concluded that there is 
strong evidence that OSM expression during wound inflammation is 
functionally connected to PMN infiltration. 
 Nair et al (2006)
22
 reviewed on the causes of persistent apical 
periodontitis. He explained that even when proper procedures are 
followed, apical periodontitis may still persist as asymptomatic 
radiolucencies because of the complexity of the root canal system. He 
listed the following factors are responsible for persistent infection: [1] 
intra radicular infection, [2] extra radicular infection, [3] foreign body 
reaction, [4] presence of true cystic lesions. 
 Brounais et al (2008)
4
 reviewed the in vitro effects of OSM 
which reduces the growth and induces differentiation of osteoblast and 
osteo sarcoma cells into osteocytic cells. OSM sensitises these cells to 
apoptosis. He designed an in vivo study model where adenoviral gene 
transfer of OSM was done in naïve and osteosarcoma – bearing rats. He 
analysed the bone variables using CT scanner, by histology and by the 
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levels of various bone markers. The results show that in osteosarcoma 
rat model OSM reduced the progression of primary bone tumor. He 
confirmed that systemic OSM over expression alters the osteoblast/ 
osteo sarcoma activity. 
 Benedicte brounais et al (2008)
5
 reviewed the in vitro studies on 
primary osteoblastic and osteosarcoma cells (normal and transformed 
osteoblasts) and have shown that oncostatin M (OSM), a member of the 
interleukin-6 family, possesses cytostatic and pro-apoptotic effects in 
association with complex and poorly understood activities on osteoblast 
differentiation. In a study he used rat osteosarcoma cells transduced with 
lentiviral particles encoding OSM to stably produce this cytokine. He 
concluded that osteosarcoma cells stably producing OSM do not develop 
resistance to this cytokine and thus could be a valuable new tool to study 
the anti-cancer effect of OSM in vivo. Moreover, OSM over-expressing 
osteoblastic cells differentiate into osteocyte-like cells, the major 
cellular contingent in bone, providing new culture conditions for this 
cell type which is difficult to obtain in vitro. 
 Hams et al (2008)
10
 reviewed the function of OSM in the face of 
an inflammatory challenge. He used a peritoneal model of acute 
inflammation to define the influence of OSM on chemokine-mediated 
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leukocyte recruitment. When compared with wild-type and IL-6- 
deficient mice, peritoneal inflammation in oncostatin M receptor 
deficient (OSMR-KO) mice resulted in enhanced monocytic cell 
trafficking. In contrast to IL-6-deficient mice, OSMR-KO mice 
displayed no difference in neutrophil and lymphocyte migration. 
Subsequent in vitro studies using human peritoneal mesothelial cells and 
an in vivo appraisal of inflammatory chemokine expression after 
peritoneal inflammation identified OSM as a prominent regulator of 
CCL5 expression. He concluded that IL-6 and OSM individually affect 
the profile of leukocyte trafficking, and they point to a hitherto 
unidentified interplay between OSM signaling and the inflammatory 
activation of NF-kB. 
 Tsai et al (2008)
33
 investigated the in situ location of OSM in 
epithelialized apical periodontitis lesions. He demonstrated that OSM 
stain was detected in the inflammatory infiltrates, epithelium, connective 
tissue and endothelium. The OSM signal was mainly expressed in 
endothelial cells (100%) followed by inflammatory infiltrates (93%), 
epithelial cells (53%) and fibroblasts (16%). He concluded that OSM 
was found to be expressed in epithelialized apical periodontitis lesions 
and would form part of the cytokine network involved in the disease 
process of apical periodontitis. 
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 Zvi Metzger et al (2009)
19
 conducted studies on apexum 
procedure and about its possible role in enhancing healing kinetics of 
periapical lesions. He performed this study to explore the safety and 
efficacy of apexum procedure. He found that there was no adverse 
effects after performing this procedure and the healing kinetics in these 
lesions were significantly enhanced. He observed a 87% and 95% 
healing rates after 3 and 6 months respectively. 
 Manojkumar et al (2010)
31
 measured the level of OSM in the 
gingival crevicular fluid and serum of chronic periodontitis patients. He 
investigated the correlation between them before and after periodontal 
therapy. Oncostatin M (OSM) is a gp130 multifunctional cytokine that 
belongs to the IL-6 subfamily and produced mainly by activated T cells, 
neutrophils, monocytes, and macrophages. More recently, it has also 
been demonstrated that OSM is produced by dendritic cells. OSM has 
been found to fulfill Koch’s postulates as an inflammatory mediator. 
OSM may act alone or synergistically with IL-6/TNF-α stimulating the 
production of IL-6, to up-regulate the production of MMPs or augment 
IL-6 production which may cause connective tissue and bone 
destruction. He found that mean OSM levels were elevated in both GCF 
and serum of chronic periodontitis patients and these levels were 
decreased proportionally after the periodontal therapy. He concluded 
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that increased OSM levels both in GCF and serum, and the decreased 
levels after initial periodontal therapy may suggest the use of OSM as an 
inflammatory biomarker in the periodontal disease.  
 Sims et al (2010)
28
 reviewed the function of gp 130 signaling 
cytokines in inflammation and maintenance of bone homeostasis. Bone 
remodeling is the process by which bone is continually renewed.This 
process occurs both within the thick cortical bone that surround the 
marrow space and on the surface of the internal network of 
bone(trabecular bone). He concluded that gp 130 cytokines regulate the 
differentiation and activity of  osteoblasts, osteoclasts and chondrocytes. 
 Carmina Barone et al (2010)
1
 conducted the Toronto study to 
assess the long term outcome of apical surgery performed on root filled 
teeth presenting with post-treatment apical periodontitis. The author 
identified three significant outcome predictors- age, preoperative root 
filling length and size of the surgical crypt. He concluded that the 
outcome was better in subjects >45 years old, teeth with inadequate root 
filling length and crypt size ≤ 10mm. 
 Fan Rong et al (2011)
26
 investigated the possible association 
between the expression of bone resorption regulators (RANKL and 
OPG) and inflammatory cell infiltration in apical periodontitis. He 
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observed the number of RANKL positive cells and the ratio of 
RANKL/OPG in apical periodontitis were significantly higher than 
those in healthy periapical tissues. He concluded that RANKL 
expression was increased with T, B Lymphocyte and macrophage 
infiltration in apical periodontitis, which is a key determinant in 
periapical bone resorption.  
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MATERIALS AND METHODS 
Armamentarium  
 Microtome 
 Autoclave 
 Hot air oven 
 Slide warmer 
 Couplin jars 
 Measuring jar 
 Weighing machine 
 APES coated slides 
 Slide carrier 
 Aluminium foil 
 Micro-pipettes 
 Toothed forceps 
 Electronic timer 
 Beakers 
 Rectangular steel tray with glass rods 
 Sterile gauze 
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 Cover-slips 
 Light microscope 
 Periosteal elevators 
 Surgical excavators 
 XCP film holder 
 E-speed X-ray films 
Reagents used 
 Conc. HCl 
 Laxbrosoln 
 APES (3 amino propyl tri ethoxvsilane) 
 Acetone 
 Citrate buffer 
 Phospho Buffer Saline (PBS) 
 3% H202 
 Deionized distilled water 
 Haematoxylin 
 Absolute alcohol 
 Xylene 
 Harri’shematoxylin 
 Eosin 
 1% acid alcohol 
Materials and Methods 
 
28 
 
Antibodies used  
1. Primary antibody — oncostatin-m Rabbit polyclonal antibody 
(SantaCruz) 
2. Secondary antibody — Rabbit Avidin Biotin Complex staining 
system (SantaCruz) 
METHODOLOGY  
Case selection: 
30 patients were selected with radiographic evidence of 
periapical lesions and with no history of systemic diseases. Initially 
conventional root canal treatment was attempted in these patients but it 
had failed. All the patients reported persistent symptomatic pain after 
initial root canal treatment. All the patients were selected within the age 
group of 20-40, because this group is less susceptible to systemic 
diseases. 
Exclusion criteria: 
Exclusion criteria included the patients with inflammatory bone 
diseases like rheumatoid arthritis, osteoarthritis and patients with 
chronic periodontitis. These cases were excluded because expression of 
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increased oncostatin-M has been detected in inflammatory bone diseases 
like rheumatoid arthritis and chronic periodontitis.  
Radiographic technique: 
Parelleling radiographic technique was used to obtain radiographs 
with minimal image distortion. XCP (Extension Cone Paralleling) film 
holder with external guiding ring was used. The guiding ring is used to 
align the x-ray aiming cylinder and ensures accuracy of the radiographic 
image. Using vernier caliper the mesio-distal diameter of the lesion is 
measured on the radiograph.  
Grouping: 
Based on the size of the lesion, the patients were divided into two 
groups- group I and group II. 
GROUP I:  
15 patients were selected in this group with lesion size less than 5mm. 
GROUP II:  
15 patients were selected with lesion size greater than 5mm. 
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SAMPLE COLLECTION AND STORAGE: 
After grouping, periapical surgery was performed in these 
patients. With the help of surgical excavators, lesions were scrapped out 
and stored in 10% buffered formalin in a sealed container. The                       
tissue specimen was allowed to fix in formalin overnight and then the 
following day, the specimen was embedded in paraffin which is made 
into blocks. One biopsy specimen from inflamed gingiva was used as 
positive control. 
PRETREATMENT OF THE SLIDES 
 The slides were first washed in tap water for 2 minutes 
 The slides were then soaked in detergent solution for 1 hour 
 After 1 hour, each slide was brushed using a scrub with the 
detergent solution and were transferred to distilled water. 
 The slides were washed in two changes of distilled water. 
 The slides were then washed in autoclaved distilled water. 
 The slides were immersed in 1 N HCL (100 ml HC1 in 900 ml 
distilled water) overnight. 
 The following day slides were taken out of acid and washed in 
autoclaved distilled water twice. 
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 All the slides were then transferred to slide trays, wrapped in 
aluminium foil and baked in hot air oven for 4 hours at 180 
degrees centigrade. 
APES coating:  
             The baked slides were then dipped in coupling jar containing 
acetone for 2 minutes. Following this the slides were dipped in APES                
(3-Amino Propyl tri Ethoxy Silane) for 5 minutes. The slides were then 
subjected to distilled water wash for 2 minutes. The slides were left to 
dry. The slides were coated with APES for better adherence of tissue 
sections to the slides. 
PREPARATION OF PARAFFIN SECTIONS: 
After the slides were dry, tissue section of 5 micron thickness 
were made in a rotary manual microtome. The ribbons of tissue section 
were transferred onto the APES coated slide from the tissue float bath 
such that two tissue bits come on to the slide with a gap in between. One 
of the tissue sections was labeled positive (P) and the other negative (N).  
For each sample 2 sections were made and transferred to 2 slides. One 
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slide was processed for immunohistochemistry and the other slide was 
stained with eosin and hematoxylin. 
HEMATOXYLIN AND EOSIN STAINING: 
The slides were dewaxed and hydrated through graded alcohol to 
water. The sections on the slides were flooded with Harri’s hematoxylin 
for 5 minutes. The slides were washed in running tap water for 5 
minutes. The slides were differentiated in 1% acid alcohol for 5 minutes. 
The slides were washed well in running tap water for 5 minutes. The 
tissue section on the slides were then stained in eosin for 30 seconds. 
The slides were washed in running tap water for 1 minute. 
STAINING PROTOCOL FOR IHC: 
The slides with tissue sections were treated with three changes of 
xylene to remove paraffin wax. They were put in descending grades of 
alcohol and then rehydrated with water. Slides were then treated with 
3% hydrogen peroxide for 30 minutes to quench endogenous 
peroxidase activity of cells that would otherwise result in non -specific 
staining. Then the slides were transferred to citrate buffer and 
autoclaved for antigen retrieval at 15 lbs pressure for 30 minutes. Then 
the slides were dipped in 3 changes of distilled water for 5 minutes 
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each. Circles were drawn around the tissues so that the antibodies added 
later on do not spread and are restricted to the circle. The tissues were 
incubated in protein blocking serum for one hour in an enclosed 
hydrated container. Then the slides were wiped carefully without 
touching the tissue section to remove excess of blocking serum.  
The primary antibody, rabbit polyclonal antibody. 1:50 dilution 
was added to the tissueP on the slide and then to the N, PBS was added. 
The slides were incubated for one hour. Then the slides were wiped 
carefully without touching the tissue section to remove excess of 
antibody and washed with three changes of cold PBS for 5 minutes. 
Then a drop of biotin conjugated secondary antibody was added on both 
the sections and the slides were incubated for 30 minutes. Later slides 
were washed in three changes of cold PBS for 5 minutes in each. The 
slides were wiped carefully without touching the tissue section to 
remove excess PBS. Then a drop of avidin biotin enzyme reagent was 
added on both the sections and the slides were incubated for 30 
minutes. The sections were washed in 3 changes of cold PBS for 5 
minutes in each. Then the slides were wiped carefully without touching 
the tissue section to remove excess PBS. Then a drop of freshly 
prepared DAB (3-Diaminobenzidine Tetra Hydrochloride a substrate 
chromogen) was added on both sections. Slides were then washed in 
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distilled water to remove excess DAB and counter stained with 
hematoxylin. The slides were placed in a tray with tap water for bluing. 
Then the slides were transferred to 70% alcohol, 100% alcohol and one 
change of xylene. The tissue sections were mounted with DPX. The 
slides were then observed under the microscope. Throughout the 
procedure care was taken not to dry the tissues. 
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Consent and Information for Endodontic Surgery 
Because non-surgical endodontic treatment is not 100% 
successful, occasionally inflammation and infection will persist in the 
bony area around the end of your tooth’s root. When this happens, the 
endodontist may have to perform an apicoectomy. In this procedure the 
endodontist opens the gum tissue near the tooth to see the underlying 
bone and to remove any inflamed and infected tissue. The very end of 
the root is also removed and frequently a small filling may be placed to 
seal the end of the root canal. Sutures or stitches are placed in the gum 
to help the tissue heal properly. In about 90% of cases in a period of six 
to eighteen months the bone will heal around the end of the root. If 
periapical surgery is indicated for the treatment of your tooth, there are 
possible complications associated with such surgery. These include 
treatment failure, swelling, discoloration, sensitivity, postoperative 
infection, jaw muscle cramps and spasm, damage or devitalization of 
adjacent teeth or roots, and paresthesia 
I fully understand the above statements in this consent form. All 
my questions have been answered. I hereby give my consent to the 
performance of periapical surgery on the tooth (or teeth) listed above. I 
further give my consent for the administration of medications, 
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anesthetics, drugs, and services deemed necessary to treat my 
endodontic problem, understanding that risks are involved. I consent to 
color photography of my teeth and to use of the excised tissue during the 
surgical procedure for scientific thesis or educational purposes in 
scientific publications or at dental meetings. 
 
 
Signature of patient / Date  
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METHODOLOGY 
 
.  
 
 
 
 
 
  
30 patients were selected without systemic diseases 
& with radiographic evidence of periapical lesions. 
Age group of the patients 20-40 years. (Male & Female).Root 
canal treatment was attempted in this patients but it had failed. 
Patients reported with symptomatic pain 
Mesio-distal diameter of the lesion was 
measured in radiograph using vernier caliper 
Group II=15 patients 
Lesion SIZE LESS 
THAN 5mm  
After informed consent from the patients, Periapical surgery was 
performed in these patients & tissue specimens were collected 
The collected tissue specimens were fixed with 10% formalin and 
processed for immunohistochemistry staining. 
The stained samples were then observed under microscope and then 
graded for OSM expression. 
Results were then statistically analyzed using Fisher’s exact test 
Group I=15 patients 
Lesion SIZE 
GREATER THAN 
5mm    
Based on the size of the lesion 
30 patients 
 
Exclusion criteria included rheumatoid arthritis & chronic periodontics 
since increased OSM expression was detected in these patients 
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Fig.1: ARMAMENTARIUM 
 
 
Fig.2: X-Ray Machine 
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Fig.3: XCP Film holder 
 
 
Fig.4: E-Speed dental X-ray film 
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Fig.5: Periapical surgery and tissue specimen collection 
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Fig.6: Primary and secondary antibody 
 
 
 
Fig.7: Paraffin blocks 
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Fig.8: Light microscope 
 
 
Fig.9: OSM Stained slides 
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Fig.10: Lesions of size <5mm 
 
 
 
 
 
 
 
 
 
Fig.11: lesions of size > 5mm 
High OSM expression was observed in lesion of size >5mm. OSM 
positive cells were stained brown. 
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Fig.12: lesions showing low degree of inflammation 
 
 
Fig.13: Lesions showing high degree of inflammation 
 
High OSM expression was observed in lesion showing high degree of 
inflammation. OSM positive cells were stained brown  
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RESULTS 
At light microscopic examination, all specimens revealed the 
morphological characteristics of apical periodontitis lesions. One section 
from each specimen was stained with eosin and hematoxylin to evaluate the 
magnitude of inflammation at the histological level. Each specimen was 
graded at 40X magnification as, grade low: inflammatory cells less than 
50% per field and grade high: inflammatory cells higher than 50% per field. 
Grading of each specimen was based on the average inflammatory 
condition in 3 consecutive microscopic fields. 
Processed immunohistochemically for OSM expression, sections 
graded as low were represented by positive stained cells less than 50% per 
field. Sections graded high exhibited positive stained cells over 50% cells.  
Grading of each specimen was based on the average OSM stained cells in 3 
consecutive microscopic fields. On examining the hematoxylin and eosin 
stained specimens, various degrees of inflammatory cell infiltration was 
observed. Among 30 specimens, 15 specimens exhibited high degree of 
inflammation and 15 specimens exhibited low degree of inflammation.  
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 Value 1 is given for specimens graded high. 
 Value 0 is given for specimens graded low. 
All the samples stained positive for OSM.  The data obtained from 
immunohistochemical analysis of group1 were entered in table 1. 11 
samples showed a high degree of inflammation and high OSM expression. 
The data obtained from immunohistochemical analysis of the group2 
were entered in table 2. 4 samples showed a high degree of inflammation 
and high OSM expression. 
The results of the present study were subjected to statistical 
analysis.Fisher’s exact test (two tail) was applied for the statistical analysis 
of the results. The Fisher's Exact test procedure calculates an exact 
probability value for the relationship between two dichotomous variables, 
as found in a two by two cross table. The program calculates the difference 
between the data observed and the data expected. This analysis is mainly 
used when the sample size is smaller. A P-value of <0.05 was considered to 
be statistically significant. 
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Table 3 and Graph1 showed increased OSM expression in lesions 
showing high degree of inflammation compared to lesion with low degree 
of inflammation. 
Table 4 and Graph 2 showed increased OSM expression in lesions 
greater than 5mm compared to smaller lesions. 
Table 5 and Graph 3 showed  the rank orders of OSM positively 
stained cells- inflammatory cells (86.7%) > endothelium (73.3%) > 
epithelium(60%) > Fibroblasts(23.3%).  
Results of the present study show that lesions of size greater than 
5mm were detected with a statistically significant increase in OSM 
expression compared to smaller lesions (P-0.011). Also it has been shown 
that OSM expression was increased with increased degree of inflammation 
(P-0.001). 
 
 
 
 
Table 1: Lesions of size greater than 5mm 
S.NO 
CASE 
NO. 
GRADING 
(degree of 
inflammation) 
GRADING 
II (OSM 
expression) 
STAINED CELLS 
FIBR
OBLA
STS 
EPIT
HELI
UM 
ENDO
THELI
UM 
INFLAM
ATORY 
CELS 
1 4430 1 1 + + - + 
2 4396 1 1 + - + + 
3 4392 1 1 - + - + 
4 4440 0 1 - + + - 
5 4363 1 1 - - + + 
6 4434 1 1 - + + + 
7 4400 1 0 - + + + 
8 4397 1 1 - + + + 
9 4390 1 0 - + + + 
10 4417 1 1 - - + + 
11 4450 1 1 - + - + 
12 4412 0 0 - + + + 
13 4356 0 1 - + - + 
14 4281 1 1 - - + + 
15 4345 0 0 - - + + 
Table 2: Lesions of size less than 5 mm 
S.NO 
CASE 
NO. 
GRADING 
(degree of 
inflammation) 
GRADING 
II (OSM 
expression) 
STAINED CELLS 
FIBR
OBLA
STS 
EPIT
HELI
UM 
ENDO
THELI
UM 
INFLAMA
TORY 
CELLS 
1 4364 0 0 + + + + 
2 4365 0 0 - + + + 
3 4366 1 1 + - - + 
4 4438 1 1 + + + - 
5 4409 0 0 - - + + 
6 4389 0 0 - + - + 
7 4439 0 0 - - + + 
8 4410 0 0 + - + + 
9 4416 0 1 - + + + 
10 4449 0 0 + - + - 
11 4322 0 0 - + - + 
12 4342 1 1 - - + + 
13 4461 0 0 - + - + 
14 4376 0 0 - + + + 
15 4413 1 0 - - + - 
Statistical Analysis 
 Fisher’s exact test (two tail) was applied for the statistical analysis of 
the results.The Fisher's Exact test procedure calculates an exact probability 
value for the relationship between two dichotomous variables, as found in a 
two by two cross table. The program calculates the difference between the 
data observed and the data expected. This analysis is mainly used when the 
sample size is smaller. A P-value of ˂0.05 mm was considered to be 
statistically significant 
Table 3: OSM expression with degree of inflammation 
 
GRADING I (Degree 
of inflammation) 
Total 
2- 
Value 
P- 
Value High Low 
N % 
N % N % 
GRADING II 
(OSM 
expression) 
High 12 80.0 3 20.0 15 50.0 
10.800 0.001 Low 3 20.0 12 80.0 15 50.0 
Total 15 100.0 15 100.0 30 100.0 
 
  
 
 
 
Table 4: OSM expression with size of the lesion 
 
IMMUNO HISTO 
CHEMISTRY - Lesion 
Size 
Total 
2 - 
Value 
P - 
Value <5 mm >5 mm 
  
N % N % 
GRADING II 
(OSM 
expression) 
High 4 26.7 11 73.3 15 50.0 
6,533 0.011 Low 11 73.3 4 26.7 15 50.0 
Total 15 100.0 15 100.0 30 100.0 
 
Table 5: Cells that have stained positive for OSM and their total 
percentage 
 
IMMUNO HISTO 
CHEMISTRY – 
Lesion Size 
Total 
2 – 
Value 
P – 
Value 
<5 mm >5 mm 
N % 
N % N % 
FIBROBLASTS 
Positive 5 33.3 2 13.3 7 23.3 
1.677 0.390 
Negative 10 66.7 13 86.7 23 76.7 
EPITHELIUM 
Positive 8 53.3 10 66.7 18 60.0 
0.556 0.456 
Negative 7 46.7 5 33.3 12 40.0 
ENDOTHELIUM 
Positive 11 73.3 11 73.3 22 73.3 
0.000 1.000 
Negative 4 26.7 4 26.7 8 26.7 
          
INFLAMMATORY 
CELLS 
Positive 12 80.0 14 93.3 26 86.7 
1.154 0.598 
Negative 3 20.0 1 6.7 4 13.3 
Total 15 100.0 15 100.0 30 100.0   
 
To summarize the results:- 
1. Increased OSM expression seen in lesions showing high degree 
of inflammation compared to lesion with low degree of 
inflammation. 
2. Increased OSM expression seen in lesions greater than 5mm 
compared to smaller lesions. 
3. The rank orders of OSM positively stained cells-        
inflammatory cells (86.7%) > endothelium (73.3%) > 
epithelium (60%) > Fibroblasts (23.3%). 
 
 
 
 
 
 
 
 
 
 Graph 1: Comparison of OSM expression with degree of inflammation 
 
Graph 2:  Comparison of OSM expression with size of the lesion 
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DISCUSSION 
Apical periodontitis is an inflammatory disorder of periradicular 
tissues caused by persistent microbial infection in the root canal system 
of the affected tooth (Kakehashi et al. 1965, Sundqvist 1976). Initially 
the tooth pulp becomes inflamed and necrotic by an autogenous oral 
microflora. The infected and necrotic pulp offers a selective habitat for 
the organisms (Fabricius et al. 1982). 
  
The endodontic environment provides a selective habitat for the 
establishment of a mixed, predominantly anaerobic flora. The presence 
of several distinct types of bacteria in the necrotic dental pulp was 
demonstrated more than a century ago (Miller, 1890). The essential role 
of micro-organisms in the etiology of apical periodontitis nevertheless 
remained uncertain for many years. Half a century later, it was shown 
(Kakehashi et al., 1965) that no apical periodontitis developed in germ-
free rats when their molar-pulps were kept exposed to the oral cavity, as 
compared with control rats with a conventional oral microflora in which 
massive periapical radiolucencies occurred.
15 
 The great significance of obligate anaerobes in                        
endodontic infections was soon established (Möller, 1966). A series of 
pathobiological studies (Fabricius, 1982) subsequently determined: (a) 
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the conditions under which the endodontic flora develops and 
establishes itself, and (b) the biological properties and endodontic 
conditions which may favor the root canal flora to become pathogenic.  
 The root canal flora of infected, untreated teeth is dominated by 
obligate anaerobes, usually belonging to the genera fusobacterium, 
porphyromonas, prevotella, eubacterium and peptostreptococcus. 
Culture studies ( Waltimo et al., 2003) and the application of scanning 
electron microscopy (Sen et al., 1995) have revealed the presence of 
fungi in canals of teeth with primary apical periodontitis. The presence 
of intraradicular viruses has so far been shown only in non-inflamed 
dental pulps of patients infected with immuno-deficiency virus.
23
 
Culture studies show that the root canal flora of previously root filled 
teeth contained a very few species of bacteria, which is predominated by 
E.faecalis.
39
   
The microbes grow in sessile biofilms, aggregates, coaggregates, 
and also as planktonic cells suspended in the fluid phase of the canal 
(Nair 1987). A biofilm (Costerton et al. 2003) is a community of 
microorganisms embedded in an exopolysaccharide matrix that adheres 
onto a moist surface whereas planktonic organisms are free-floating 
single microbial cells in an aqueous environment. Bacterial aggregations 
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in the biofilm have been thought to be the cause of therapy-resistant 
apical periodontitis. Microorganisms protected in biofilms are greater 
than one thousand times more resistant to biocides as the same 
organisms in planktonic form (Wilson 1996, Costerton & Stewart 
2000).
39
 
Essentially, this habitat-adapted polymicrobial community 
residing in the root canal has several biological and pathogenic 
properties, such as antigenicity, mitogenic activity, chemotaxis, 
enzymatic histolysis, and activation of host cells. The microbes in the 
root canal can advance, or their products can egress, into the periapex. In 
response, the host mounts an array of defenses consisting of several 
classes of cells, intercellular messengers, antibodies, and effector 
molecules. The microbial factors and host defense forces encounter, 
clash with, and destroy much of the periapical tissue, resulting in the 
formation of various categories of apical periodontitis lesions. 
 In spite of the formidable defense, the body is unable to destroy 
the microbes most of which are well entrenched in the sanctuary of the 
necrotic root canal, which is beyond the reaches of body defenses. 
Therefore, apical periodontitis is not self-healing.
23
 The treatment of 
apical periodontitis consists of eliminating infection from the root canal 
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and preventing re-infection by a hydraulic seal of the root canal space. 
Nevertheless, endodontic treatment can fail for various reasons. 
The goal of the root canal treatment consists of eradicating the 
root canal microbes or substantially reducing the microbial load and 
preventing re-infection by root canal filling (Nair et al. 2005). When the 
treatment is done properly, healing of the periapical lesion usually 
occurs with hard tissue regeneration that is characterized by reduction of 
the radiolucency on follow-up radiographs. Nevertheless, a complete 
healing of calcified tissues or reduction of the apical radiolucency does 
not occur in all root canal treated teeth.
22 
The presence or absence of 
signs and symptoms (pain, swelling and sinus tract) and the PAI scores 
were used as outcome measures. 
Periapical index (PAI) scores provides an ordinal scale of five 
scores ranging from “healthy” to “severe periodontitis with exacerbating 
features”. The PAI is based on reference radiographs with verified 
histological diagnosis.
14
 The PAI scores:  
1. Normal periapical structures  
2. Small changes in bone structure 
3. Changes in bone structure with some mineral loss 
4. Periodontitis with well defined radiolucent area 
5. Severe periodontitis with  exacerbating features 
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Treatment was considered a success when clinically, there was 
absence of signs and symptoms and radiographically the PAI score was 
1 or 2 or there was a typical scar tissue formation. Treatment was 
considered a failure when clinical signs and symptoms were present or 
when the PAI score was 3 or higher.
1 
Periapical radiolucencies persist 
when treatment procedures have not reached a satisfactory standard for 
the control and elimination of infection. 
The prolonged healing process of many periapical lesions has 
been attributed to the activated macrophages in the lesion that may 
maintain their state of activation long after the initial cause of their 
activation has been eliminated by root canal treatment; namely, the 
activation state may outlive its useful purpose and become a burden by 
inhibiting resolution of the lesion. The production of bone-resorbing 
cytokines by these cells may persist for many months after the 
completion of the root canal treatment, thus preventing resolution of the 
periapical bone defects.
19 
OSM production by activated macrophages 
and the bone resorbing property of this cytokine could be one of the 
possible reason for persistent periapical periodontitis lesions.  
Oncostatin M (OSM) is a multifunctional cytokine belonging to 
the Interleukin (IL)-6 family [1] which also includes IL-11, IL-27,             
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IL-31, leukemia inhibitory factor (LIF), ciliary neurotrophic factor 
(CNTF), cardiotrophin-1 (CT-1), cardiotrophin-like cytokine (CLC) and 
neuropoietin (NP).
4
OSM regulates cell growth and differentiation in a 
wide variety of biological systems, including hematopoiesis, 
neurogenesis, and bone homeostasis.
5
 Hence OSM is regarded as a 
pleiotropic cytokine since it participates in a variety of physiological 
processes. Marc Vasse analysed the effect of OSM on angiogenesis and 
found that OSM can induce an angiogenic effect on the capillary 
endothelial cellswhich could be implicated in the pathological process of 
atherosclerosis.
35
 Gomez suggested the potential role of OSM in the 
regulation of complex cellular processes such as gene activation, cell 
survival, proliferation and differentiation.
7
Human OSM is a secreted 
glycoprotein which is initially translated as a 252 amino acid 
polypeptide with a 25 residue hydrophobic signal sequence at the N-
terminus that is removed during the secretion process.
6
 
OSM was first identified in the human myelocytic leukemia cell 
line U937, after treatment with phorbol esters. Subsequent studies 
identified activated T lymphocytes and macrophages, cell cultures 
derived from acquired immunodeficiency virus (AIDS)-related Kaposi's 
sarcoma (Nair et al., 1992) and retrovirus-infected CD4 T-cells as 
sources of OSM  mRNA. OSM secretion occurs through a 2 step 
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mechanism in Polymorphonuclear neutrophils, consisting of early 
release of a preformed stock followed by de novo protein synthesis.
9
 
Glycoprotein 130(gp130) is a receptor subunit capable of 
intracellular signaling that are required for the cellular action of a wide 
range of cytokines.
28
 Every cytokine that binds to gp130 generates 
specific intracellular signaling events by forming specific 
receptor:ligand complexes. IL-6 cytokine family members, sharing this 
common signal transducer gp130, has been found to be responsible for 
bone remodeling.
11
Activation of gp130 by these cytokines occurs 
through different mechanisms. IL-6, IL-11, and IL-27 activate gp130 
after binding to specific nonsignaling receptor subunits, which then 
trigger the homodimerization and activation of gp130.
2 
In contrast, cytokines including LIF and OSM engage gp130 to 
form a heterodimer interaction with one of two gp130-related proteins, 
LIFR or OSMR. These distinct modes of gp130 activation may provide 
a molecular basis for the pattern of cellular events orchestrated by these 
related factors .
10
 OSM signals through 2 different receptors in humans. 
[1] LIF/OSM shared receptor which shares high-affinity binding with 
LIF,  and [2] the OSM-specific receptor which binds OSM uniquely.
21 
Leukemia inhibitory factor(LIF), an evolutionarily related protein is 
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structurally similar to OSM and both have similar biologic activities on 
a variety of target cells, including hematopoietic cells, hepatocytes, 
neurons and bone cells.
3
Based on the action of LIF & OSM in bone 
cultures, these cytokines are regarded as the potent remodeling agents 
with pleiotropic effects on bone formation and resorption.
34 
OSM has been found to enhance the differentiation and 
proliferation of osteoblasts during bone development and also induces 
the formation of osteoclasts that contribute in bone homeostasis.
18 
OSM 
stimulate collagenase-3 and tissue inhibitors of metalloproteinases 
expression in osteoblasts and these effects may be involved in mediating 
the bone remodeling action of this cytokine.
34
 In accordance with studies 
performed by Cawston et al, Hui et al it has been suggested that OSM 
appears to be an important cofactor with other pro-inflammatory 
cytokines such as IL-1, TNF-α and IL-17 in mediating cartilage/bone 
destruction. When these pro-inflammatory cytokines are over expressed 
in combination with OSM in murine joints, a marked increase in damage 
to the joint tissues is observed. In contrast to the information presented 
here, A.F Wahl presented a study where he showed that OSM can 
modulate the expression of human acute phase proteins and protease 
inhibitors and thereby limiting tissue damage at the sites of 
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inflammation.
36 
This may be due to the differences in the sources and 
purity of the proteins, in addition to the experimental design variations. 
RANKL is a TNF superfamily member and an essential mediator 
of osteoclastogenesis. It is produced from osteoblastic- stromal cells, 
synovial fibroblasts, chondrocytes and activated T lymphocytes. This 
TNF-related cytokine and its receptor, RANK, are considered key 
factors in osteoclast differentiation, and RANK signalling is vital for 
osteoclast activation and survival. Furthermore, there was increased 
expression of RANK and its ligand RANKL in the inflammatory cells, 
in inflamed synovium and in articular cartilage of knee joints treated 
with the cytokine combinations. In vivo, oncostatin M in combination 
with either IL-1 or tumor necrosis factor alpha represents cytokine 
combinations that promote bone destruction.
13
 
The expression of increased OSM has been demonstrated in 
inflammatory bone diseases like rheumatoid arthritis and osteoarthritis.
12 
Increased expression of OSM has also been detected in chronic 
periodontitis. S.J.Lin et al established a possible modulatory role for 
OSM in the inflammatory cascade of chronic periodontitis.
17 
Manoj 
Kumar et al measured the levels of OSM in the gingival crevicular fluid 
and serum of the chronic periodontitis patients.  He found a significant 
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correlation between the levels of OSM in serum and gingival crevicular 
fluid. 
31
 Increased OSM level both in gingival crevicular fluid and 
serum, and the decreased levels after initial periodontal therapy may 
suggest use of OSM as an inflammatory biomarker in the periodontal 
disease. 
Clinically it has been demonstrated that OSM expression has 
been detected in advanced apical periodontitis lesions. Tsai et al 
demonstrated expression of OSM in epithelialised apical periodontitis 
lesions. He concluded that OSM forms a part of the cytokine network 
that is involved in the disease process of apical periodontitis lesions. 
OSM can be regarded as the cytokine responsible for the expansion of 
these lesions inside the bone.
33
 
However the presence of OSM in smaller apical periodontitis 
lesions with minor alterations in the bone structure (i.e) with non-
extensive bone destruction has not been studied. Hence the aim of the 
present study is to investigate the expression of OSM in apical 
periodontitis lesions. The objective of the present study is to investigate 
the expression of OSM in apical periodontitis lesions and to compare the 
expression of OSM in lesions of size greater than 5mm and lesions of 
size less than 5mm. 
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In our study 30 periapical lesions of pulpal origin were collected 
with informed consent from the patient at the time of apical surgery. 
Exclusion criteria included the patients with inflammatory bone diseases 
like rheumatoid arthritis, osteoarthritis and patients with chronic 
periodontitis
37
. These cases are excluded because the studies conducted 
by Hui et al (1997) had shown increased levels of oncostatin-M  
expression in inflammatory diseases like rheumatoid arthritis, 
osteoarthritis and chronic periodontitis. All the patients were without 
systemic diseases and with radiographic evidence of periapical lesions 
including periradicular alveolar bone loss. Initially non surgical 
endodontic treatment was attempted in these patients but the treatment 
has failed.  
Most of the patients were symptomatic with persistent pain and 
with radiographic evidence of non -healing periapical lesions. Age of the 
patient is an important inclusion criteria in this study. Age group was 
standardized in the range between 20-40yrs because in this period 
patients are less susceptible to systemic diseases. Paralleling cone 
radiographic technique was followed to standardize radiographic 
procedures. 
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The collected periapical lesions were divided into 2 Groups, 
Group I (n=15) samples which contained lesions of size >5mm and 
Group II (n=15) samples which contained lesions of size <5mm. The 
grouping was done based on the size of the lesion. The classical Toronto 
study performed by Wang et al (2004) revealed that lesion size is a 
major predictor of outcome of apical surgery. Better treatment outcome 
was observed in teeth with smaller lesions (<5mm) compared to larger 
lesions. 
38 
Since size of the lesion is a major predictor of success, in the 
present study grouping was done based on this factor. Group I consisted 
of lesions of size greater than 5mm and group II consisted of lesions of 
size less than 5mm. The collected samples were then preserved. Because 
of the superior preservation of morphology, formalin- fixed paraffin-
embedded (FFPE) tissue remains today the medium of choice for most 
clinical and research studies.
41
 The collected tissue specimens were 
fixed with 10% buffered formalin overnight and dehydrated in an 
ascending series of graded alcohol. Finally the fixed, dehydrated 
specimens were embedded in paraffin and made in to blocks.
 
However, the loss of immunoreactivity by many antigens caused 
as a result of fixation in formalin has introduced many challenges.An 
entirely new approach for the restoration of immunoreactivity in FFPE 
tissue sections was reported by Shi et al 1991. However, another major 
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step forward in the use of heat was reported by Cattoretti et al. Based on 
his technique, in the present study after deparaffinizing and rehydrating 
the tissue sections, the slides are immersed in an aqueous solution 
commonly referred to as a “retrieval solution”.27 The solution used here 
is citrate buffer at a pH of 6. The slides were then transferred to citrate 
buffer and autoclaved for 30 minutes at 15lbs pressure. 
In this study indirect staining technique was used where an 
unconjugated primary antibody first binds to the antigen. The primary 
antibody (Rabbit antihuman SC-129, santacruz Biotechnology) used in 
this study was diluted with phosphate buffered saline at a ratio of 1:50. 
An enzyme-labelled secondary antibody directed against the primary 
antibody (now the antigen) is then applied, followed by the substrate-
chromogen solution. In this study, Diaminobenzidine is used as the 
chromogen substrate for localizing the antibody binding.
32 
If the primary antibody is made in rabbit or mouse, the secondary 
antibody must be directed against rabbit or mouse immunoglobulins, 
respectively. This method is versatile because a variety of primary 
antibodies from the same species can be used with the same conjugated 
secondary antibody. The procedure is also more sensitive as several 
secondary antibodies are likely to react with a number of different 
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epitopes of the primary antibody thus amplifying the signal as more 
enzyme molecules are attached per each target site.
41 
Another section is made from each specimen and stained with 
hematoxylin and eosin (H & E). The sections were stained with 
hematoxylin and eosin to evaluate the magnitude of inflammation at the 
histological level. 
In the present study all the samples stained with anti-OSM 
antibody showing the generalized presence of the OSM cytokine in all 
the cases with persistent periapical periodontitis. Both OSM stained 
slides and eosin-hematoxylin stained slides were observed under light 
microscopy at 40 X and graded. Grading of the samples were performed 
similar to the study done by Tsai et al (2008). H & E stained slides were 
graded to evaluate the degree of inflammation. Grade low- inflammatory 
cells less than 50% per field. Grade high-inflammatory cells greater than 
50% per field. Grading of each specimen was based on the average 
inflammatory condition in 3 consecutive fields. 
Immunohistochemically stained slides were graded for the 
expression of OSM which will take up a brown stain. 
Immunohistochemically processed slides were graded for OSM 
expression in a similar manner as described above. Sections graded low 
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were represented by positive stained slides less than 50% of the total 
cells. Sections were graded high when the positive stained cells were 
greater than 50% per field. Grading of each specimen was based on the 
average positive cell expression in 3 consecutive fields. 
Since the sample size was smaller, Fisher’s exact test was applied 
for statistical analysis of the results. A P-value < 0.05% was considered 
to be statistically significant. Statistical analysis of the results showed a 
significantly higher OSM expression in group I [lesions of size greater 
than 5 mm] compared to group II[lesions of size less than 5mm] 
P=0.011.  Differences in OSM expression between tissues with high and 
low levels of inflammation were subsequently analysed using Fisher’s 
exact test. A significantly higher OSM expression was noted in lesions 
with high levels of inflammation compared to tissues with low levels of 
inflammation. The results indicate a higher OSM expression in larger 
lesions and lesions showing higher degree of inflammation. 
OSM expression was found in epithelium, inflammatory 
infiltrates, endothelium and connective tissue. The rank orders with 
respect to OSM positively stained cells were found as follows: 
inflammatory infiltrates (86.7%) > endothelium (73.3%) > epithelium 
(60%) > fibroblasts (23.3%). OSM is not expressed in negative controls 
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of apical periodontitis lesions. In inflamed gingival specimens OSM was 
detected in epithelium, endothelium, fibroblasts and inflammatory 
infiltrates. The expression of OSM might play a role in the pathogenesis 
of apical periodontitis lesions.
33
 
The mechanism responsible for OSM expression in apical 
periodontitis lesions can be explained as follows. Apical periodontitis 
lesions are believed to result from continuous antigenic stimulation from 
inflamed or necrotic root canals. A classical study performed by 
kakehashi et al in 1965 showed an association between bacteria and 
endodontic infection. According to a study performed by Suda et al 
(2002) OSM was also found to be synthesized by bacterial 
lipopolysaccharides in dendritic cells. He suggested that OSM produced 
by dendritic cells at infectious sites may play a role in modulating 
inflammatory responses.
30 
Therefore OSM expression in apical 
periodontitis lesions may be induced directly by the bacteria from 
necrotic and infected pulps or indirectly by the inflammatory mediators 
generated by resident cells. Thus these cells may play an important role 
in the pathogenesis of apical periodontitis lesions by controlling the 
synthesis of inflammatory mediators and OSM.    
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Palmqvist et al (2002) implicated that OSM is a mediator of bone 
destruction.
24 
OSM was reported to induce tissue type Plasminogen             
Activator (t-PA) expression in vitro.
29 
Plasminogen activating system 
participates in degradation of bone matrix. Stimulation of osteoclast 
differentiation in vitro by OSM has also been studied (Richards et al).
25
 
Apical periodontitis lesions are believed to result from continuous 
antigenic stimulation from inflamed and necrotic root canals. 
As the periapical lesions tend to grow within the jaw bone, it is 
understandable that expansion of the lesion is possible only with bone 
destruction. Bone expansion occurs by activated osteoclasts at the lesion 
site. As OSM participate in bone degradation, taken together it is 
hypothesized that the possible mechanism by which lesion growth 
occurs within the jaw bone is through OSM expression pathway. The 
results of the present study correlates with the above mentioned 
explanation that increased OSM expression is seen in larger lesion 
compared to smaller lesion. Increased OSM presence was seen in 
growing lesions.
 
OSM has received wide attention because of its participation in 
diversified physiological processes. Tsai et al demonstrated the role of 
OSM in the expansion of epithelialized apical periodontitis lesions. The 
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findings of our study indicated that OSM is not only responsible for the 
growth of the lesions but also it could be one of the possible reasons 
which actually delays the healing process.  Goren proved that increased 
OSM expression is functionally connected to the polymorphonuclear 
neutrophil infiltration and associated with impaired healing in 
chronically inflamed lesions.
8 
All the cases selected in our study were 
refractory to nonsurgical endodontic procedure. In our study there is 
generalized presence of OSM irrespective of the size of the lesion. This 
strongly suggests OSM expression by the resident cells is mainly 
responsible for the impaired bone deposition at the lesion site and as a 
consequence delayed healing. By performing periapical surgery and 
elimination of the residing inflammatory periapical tissue will help in 
elimination of OSM and thereby accentuates healing mechanisms. 
In addition increased OSM expression is seen in lesions greater 
than 5mm compared to smaller lesions, which could be the possible 
cause for extensive bone destruction in larger lesions. This could also be 
the reason for better treatment outcome observed in smaller (≤5mm) 
lesions compared to larger lesions after apical surgery.
38  
The expression 
of OSM increases with the grade of inflammation in apical periodontitis 
lesions showing that the resident cells [inflammatory infiltrates, 
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endothelium, epithelium and fibroblasts], act as a reservoir of OSM that 
could be secreted at certain stages of inflammation. 
In the present study OSM was detected in all the periapical 
lesions that are persistent after initial endodontic therapy. Presence of 
OSM could be the possible reason behind the failure of non surgical 
endodontic management. Increased OSM expression was observed in 
lesions of size greater than 5mm and in lesions showing high degree of 
inflammation. Thus the role of OSM in the pathogenesis of apical 
periodontitis lesion is worthy of further investigation. 
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SUMMARY 
The purpose of the study is to investigate the expression of 
Oncostatin M (OSM) in apical periodontitis lesions and to compare the 
expression of OSM in lesions of size greater than 5mm and lesions of 
size less than 5mm. OSM is a pleiotropic cytokine which has a role in 
the pathogenesis of many inflammatory diseases and brings about bone 
resorption. 
 In our study, 30 periapical lesions of pulpal origin were collected 
with informed consent from the patient at the time of apical surgery. 
Exclusion criteria included the patients with inflammatory bone diseases 
like rheumatoid arthritis, osteoarthritis and patients with chronic 
periodontitis. All the patients are without systemic diseases and with 
radiographic evidence of periapical lesions including periapical alveolar 
bone loss. Initially non surgical endodontic treatment was attempted in 
these patients but the treatment has failed. Age of the patient is an 
important inclusion criteria in this study. Age group was standardized in 
the range between 20-40yrs, because in this period patients are less 
susceptible to systemic diseases. Paralleling cone radiographic technique 
was followed to get the accurate mesio-distal dimension of the lesion. 
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        The collected periapical lesions were divided into 2 Groups, Group 
I (n=15) samples and Group II (n=15) samples. The grouping was done 
based on the size of the lesion. Group I consisted of lesions of size 
greater than 5mm and group II consisted of lesions of size less than 
5mm. the collected samples were then preserved. Because of the 
superior preservation of morphology, formalin- fixed paraffin-embedded 
(FFPE) tissue remains today the medium of choice for most clinical and 
research studies. The collected tissue specimens were fixed with 10% 
buffered formalin overnight and dehydrated in an ascending series of 
graded alcohol. Finally the fixed, dehydrated specimens were embedded 
in paraffin and made in to blocks. 
5 micron thin sections were made from the paraffin blocks and 
the sections were transferred to the slides. The slides were processed 
immunohistochemically to locate the OSM antigen. Another 5 micron 
section from the samples were made and stained with eosin and 
hematoxylin to assess the magnitude of inflammation. The slides were 
then observed under light microscope at 40 X and graded. 
Results of the present showed that all the samples stained positive for 
OSM. Increased OSM expression was observed in group1 (i.e) lesions 
greater than 5 mm compared to smaller lesions. In addition increased 
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OSM expression was observed in lesions showing high degree of 
inflammation. The results of the present study agree with the study 
performed by Tsai et al (2008) where OSM expression was increased 
with increase in the degree of inflammation. 
 The OSM has received considerable attention because of its 
participation in many inflammatory diseases. OSM could be detected in 
areas of the chronic apical periodontitis lesions, suggesting that OSM, 
stored in the cytosol of epithelial cells, inflammatory, cell, fibroblasts, 
and endothelial cells, may represent a reservoir of OSM activity that can 
be released at certain stages of the inflammatory reaction. In addition, 
the expression of OSM increases with the grade of inflammation in 
apical periodontitis lesions. Thus the role of OSM in the pathogenesis of 
apical periodontitis lesion is worthy of further investigation. 
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CONCLUSION 
Within the limitations of the present study, it can be concluded that 
(i) All the tissue specimens obtained from periapical surgery 
stained with anti OSM antibody showing the generalized 
presence of the OSM cytokine in cases with persistent 
periapical periodontitis. 
(ii) OSM forms the cytokine network that is responsible for the 
bone resorption associated with periapical lesions. 
(iii) Immunoreactivity of OSM was expressed in epithelium, 
endothelium, inflammatory infiltrates and fibroblasts. The 
OSM signal was expressed in the following rank order- 
inflammatory infiltrates (86.7%) > endothelium (73.3%) > 
epithelium (60%) > fibroblasts (23.3%) 
(iv) Increased OSM expression was observed in lesions greater 
than 5mm compared to smaller lesions.  
(v) Increased OSM expression was observed in lesions with 
increased degree of inflammation. 
(vi) Increase in OSM expression can denote the increase in degree 
of inflammation of periapical lesions. 
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